Details
Medpace is a global full-service clinical research organization that supports pharmaceutical, biotechnology, and medical device companies in the development of new therapies. Headquartered in the United States, Medpace provides comprehensive services across all phases of clinical trials, from early-stage development to post-approval studies.
The company specializes in therapeutic areas such as oncology, cardiology, metabolic diseases, and rare conditions, offering scientific, regulatory, and operational expertise. Its integrated model allows Medpace to manage all aspects of a clinical trial, including study design, patient recruitment, data management, and regulatory submissions.
With offices in North America, Europe, and Asia-Pacific, Medpace conducts trials worldwide while maintaining a strong focus on quality, consistency, and regulatory compliance. The company is known for its hands-on, scientifically driven approach and long-term client partnerships. It continues to invest in clinical innovation and operational efficiency to accelerate the development of safe and effective medical treatments.